The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer

Cancer Immunology Immunotherapy

Volumn 43, Issue 1, 1996, Pages 1-9

  Uotila, Pekka ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Cancer immunology; Cyclic AMP; Histamine; Oxygen intermediates; Prostaglandin E2

Indexed keywords

CYCLIC AMP; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 2; PROSTAGLANDIN E2; SUPEROXIDE;

CELLULAR IMMUNITY; HOST RESISTANCE; HUMAN; MACROPHAGE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY;

EID: 0029831729     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03354243     Document Type: Review

References (118)

1. Abramson SL, Gallin JI (1990) IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 144: 625
2. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J Immunol 148: 2845
3. Angel P, Karin M (1991) The role of Jun, Fos and AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129
4. Arend WP, Gordon DF, Wood WM, Janson RW, Joskin FG, Jameel S (1989) IL-1β production in cultured human monocytes is regulated at multiple levels. J Immunol 143: 118
5. Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226
6. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G (1994) Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 156: 480
7. Barinaga M (1995) Two major signaling pathways meet at MAP-kinase. Science 269: 1673
8. 2-receptor blockers. Xenobiotica 14: 399
9. 2 or the β-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158: 182
10. Bennet A, Civier A, Hensby CN, Melhuish PB, Stamford IF (1987) Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 28: 315
11. Beutler B, Van Huffel C (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667
12. Bravo R, Nueberg M, Burckhardt J, Almendral J, Wallich R, Müller R (1987) Involvement of common and cell type-specific pathways in c-fos gene control: Stable induction by cAMP in macrophages. Cell 48: 251
13. 125iodocyanopindolol. Life Sci 29: 2189
14. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G (1991) Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173: 869
15. Chiu R, Angel P, Karin M (1989) Jun-B differs in its biological properties from, and is a negative regulator of, cJun. Cell 59: 979
16. Coleman RA, Smith WL, Narumiya S (1994) VIII International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205
17. Cook SJ, McCormick F (1993) Inhibition by cAMP of Rasdependent activation of Raf. Science 262: 1069
18. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041
19. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209
20. Di Giovine F, Duff GW (1990) Interleukin 1: the first interleukin. Immunol Today 11: 13
21. Dohlsten M, Sjögren HO, Carlsson R (1987) Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production. Cell Immunol 109: 65
22. - T cells. Immunol Lett 20: 29
23. Donnelly RP, Fenton MJ, Kaufmann JD, Gerrard TL (1991) IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J Immunol 146: 3431
24. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183
25. 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci USA 84: 6995
26. Engelhard VH (1994) How cells process antigens. Sci Am 271: 44
27. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS (1989) IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142: 3857
28. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 95: 1669
29. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815
30. Fischer H, Hedlund G, Kalland T, Sjögren HO, Dohlsten M (1990) Independent regulation of IFN-α and tumor necrosis factor by IL-1 in human T helper cells. J Immunol 145: 3767
31. Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47: 412
32. Galbraith RA, Michnovicz JJ (1989) The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med 321: 269
33. Gantz I, Munzert G, Tashiro T, Schäffer M, Wang L, DelValle J, Yamada T (1991) Molecular cloning of human histamine H2 receptor. Biochem Biophys Res Commun 178: 1386
34. Garcia-Penarrubia P, Bankhurst AD, Koster FT (1989) Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170: 601
35. Gastl G, Niederwieser D, Marth C, Huber H, Egg D, Schuler G, Margreiter R, Braunsteiner H, Huber C (1984) Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood 64: 288
36. Goodman Gilman A, Rall TW, Nies AS, Taylor P (1990) Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. Pergamon, New York
37. Goto T, Herberman RB, Maluish A, Strong DM (1983) Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol 130: 1350
38. Halliwell B, Gutteridge JMC (1991) Free radicals in biology and medicine, 2nd edn. Clarendon, Oxford
39. Hansson M, Asea A, Ersson U, Hermodsson S, Hellstrand K (1996) Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 156: 42
40. 2. Proc Natl Acad Sci USA 86: 3803
41. 2 of TNFα and IL-1 production by human monocytes. Immunology 66: 376
42. Hellstrand K, Hermodsson S (1987) Differential effects of histamine receptor antagonists on human natural killer cell activity. Int Arch Allergy Appl Immunol 84: 247
43. Hellstrand K, Hermodsson S (1989) An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 89: 334
44. 2-receptor-mediated NK-cell activation. Scand J Immunol 31: 631
45. Hellstrand K, Asea A, Hermodsson S (1990) Role of histamine in natural killer cell-mediated resistance against tumor cells. J Immunol 145: 4365
46. Hellstrand K, Asea A, Dahlgren C, Hermodsson S (1994) Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol 153: 4940
47. 2 subtype. J Biol Chem 268: 7759
48. Hotermans G, Bury T, Radermecker MF (1991) Effect of histamine on tumor necrosis factor production by human monocytes. Int J Allergy Appl Immunol 95: 278
49. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O (1994) Signaling by the cytokine receptor superfamily; JAKs and STATs. Trends Biochem Sci 19: 222
50. Israel A (1994) NF-AT comes under control. Nature 369: 443
51. Jain J, McCaffrey PG, Valge-Archer VE, Rao A (1992) Nuclear factor of activated T cells contains Fos and Jun. Nature 356: 801
52. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase Type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049
53. Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9: 222
54. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556
55. Katz P, Zaytoun AM, Fauci AS (1982) Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol 129: 287
56. Khan MM, Sansoni P, Engleman EG, Melmon KL (1985) Pharmacologic effects of autacoids on subsets of T cells. J Clin Invest 75: 1578
57. Khan MM, Sansoni P, Silverman ED, Engleman EG, Melmon KL (1986) Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol 35: 1137
58. Kishimoto T, Taga T, Akira S (1994) Cytokine signal transduction. Cell 76: 253
59. Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP (1991) Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680
60. Kobayaski M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170: 827
61. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84: 46
62. 2-adrenergic receptor. Science 238: 650
63. Krause DS, Deutsch C (1991) Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immunol 146: 2285
64. Kubota Y, Sunouchi K, Ono M, Sawaka T, Muto T (1992) Local immunity and metastasis of colorectal carcinoma. Dis Colon Rectum 35: 645
65. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263: 5380
66. Kärre K, Hansson M, Kiessling R (1991) Multiple interactions at the natural killer workshop. Immunol Today 12: 343
67. Last-Barney K, Homon CA, Faanes RB, Merluzzi VJ (1988) Synergistic and overlapping activities of tumor necrosis factor-α and IL-1. J Immunol 141: 527
68. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J Immunol 143: 3020
69. Liou H-C, Baltimore D (1993) Regulation of the NK-kB/rel transcription factor and IkB inhibitor system. Curr Opin Cell Biol 5: 477
70. Marx J (1993) Forging a path to the nucleus. Science 260: 1588
71. Marx J (1993) Two major signal pathways linked. Science 262: 988
72. Mary D, Aussel C, Ferrua B, Fehlmann M (1987) Regulation of interleukin2 synthesis by cAMP in human T cells. J Immunol 139: 1179
73. McCaffrey PG, Luo C, Kerppola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, Hogan PG (1993) Isolation of cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750
74. McLemore TL, Hubbard WC, Litterst CL, Liu MC, Miller S, McMahon NA, Eggleston JC, Boyd MR (1988) Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res 48: 3140
75. Meade EA, Smith WL, DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J Biol Chem 268: 6610
76. 2 production by human chondrosarcoma cells. J Immunol 139: 166
77. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM (1994) Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J Biol Chem 269: 21 322
78. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11 693
79. Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR (1988) Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 114: 588
80. 2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum 33: 840
81. Newton RC (1985) Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunol 56: 441
82. Niiro H, Otsuka T, Tanabe T, Hara S, Kuga S, Nemoto Y, Tanaka Y, Nakashima H, Kitajima S, Abe M, Niho Y (1995) Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85: 3736
83. Northrop JP, Ullman KS, Crabtree GR (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 268: 2917
84. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR (1994) NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497
85. O'Banion MK, Winn VD, Young DA (1992) cDNA cloning and functional activity of glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 89: 4888
86. Ogasawara H, Fujitani T, Drzewiecki G, Middleton E (1986) The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J Allergy Clin Immunol 78: 321
87. Ozaki M, Morii H, Qvist R, Watanabe Y (1994) Interleukin-1β induces cytosolic phospholipase A2 gene in rat C6 glioma cell line. Biochem Biophys Res Commun 205: 12
88. Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76: 241
89. Pelkonen O, Breimer DD (1994) Role of environmental factors in the pharmacokinetics of drugs: considerations with respect to animal models, P-450 enzymes, and probe drugs: In: Welling PG, Balant LP (eds) Handbook of experimental pharmacology, vol 110. Pharmacokinetics of drugs. Springer, Berlin Heidelberg New York, pp 289
90. Pene J, Rousset F, Briere F, Chretien I, Paliard X, Banchereau J, Spits H, De Vries JE (1988) IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J Immunol 141: 1218
91. Phipps RP, Stein SH, Roper RL (1991) A new view of prostaglandin E regulation of the immune response. Immunol Today 12: 349
92. 2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. Am J Med 77 [Suppl 5B]: 57
93. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min H-Y, Lin L (1992) IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 148: 808
94. Ramstedt U, Ng J, Wigzell H, Serhan CN, Samuelsson B (1985) Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects of intracellular cAMP and target cell binding. J Immunol 135: 3434
95. Riabowol KT, Fink JS, Gilman MZ, Walsh DA, Goodman RH, Feramisco JR (1988) The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature 336: 83
96. Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122: 518
97. 2 and the increase of intracellular cAMP inhibits the expression of interleukin-2 receptors in human T cells. Eur J Immunol 18: 1791
98. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61: 1132
99. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785
100. Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 26: 496
101. Severn A, Rapson NT, Hunter CA, Liew FY (1992) Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 148: 3441
102. Smith KA (1990) Interleukin-2. Sci Am 262: 26
103. Smith WL, Marnett LJ (1991) Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083: 1
104. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82: 2790
105. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL (1990) Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145: 1430
106. Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL (1994) Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J Immunol 152: 3024
107. 2. J Exp Med 180: 2365
108. Strieter RM, Remick DG, Ham JM, Colletti LM, Lynch JP, Kunkel SL (1990) Tumor necrosis factor-alpha gene expression in human blood. J Leukoc Biol 47: 366
109. Subramanian N, Bray MA (1987) Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 138: 271
110. Theoharides TC, Kops SR, Bondy PK, Askenase PW (1985) Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacol 34: 1389
111. Tønnesen H, Knigge U, Bülow S, Damm P, Fischerman K, Hesselfeldt P, Hjortrup A, Pedersen IK, Pedersen VM, Siemssen OJ, Svendsen LB, Christiansen PM (1988) Effect of cimetidine on survival after gastric cancer. Lancet 2: 990
112. Trinchieri G (1993) Interleukin-12 and its role in the generation of ThI cells. Immunol Today 14: 335
113. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, AsteAmezaga M, Kubin M, Valiante NM, Chehimi J (1992) Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 4: 355
114. Trinchieri G, Scott P (1994) The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 15: 460
115. 2 formation and histamine action in cancer immunotherapy. Cancer Immunol Immunother 37: 251
116. Uotila P, Vapaatalo H (1984) Synthesis, pathways and biological implications of eicosanoids. Ann Clin Res 16: 226
117. Van der Pouw Kraan TCTM, Boeije LCM, Smeenk RJT, Wijdenes J, Aarden LA (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775
118. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated AMP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065